» Articles » PMID: 25231510

Fasting Glucose and HbA1c Levels As Risk Factors for the Development of Hypertension in Japanese Individuals: Toranomon Hospital Health Management Center Study 16 (TOPICS 16)

Overview
Journal J Hum Hypertens
Date 2014 Sep 19
PMID 25231510
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

We investigated the effect of elevated concentrations of fasting plasma glucose (FPG) or hemoglobin A1c (HbA1c) on the risk of development of hypertension among apparently healthy Japanese. Studied were 9584 individuals without known diabetes and hypertension. During a 5-year follow-up period, 1098 individuals developed hypertension. Elevated concentrations of FPG, rather than of HbA1c, were significantly predictive of future hypertension. Compared with the lowest quartile category of FPG (<4.9 mmol l(-1)), the second (4.9-<5.2 mmol l(-1)), third (5.2-<5.6 mmol l(-1)) and highest (⩾ 5.6 mmol l(-1)) quartile categories had age-, sex- and body mass index-adjusted odds ratios (95% confidence interval) of 1.35 (1.10, 1.66), 1.39 (1.13, 1.71) and 1.85 (1.51, 2.28) for hypertension, respectively. In the highest quartile of FPG, the multivariate-adjusted OR was 1.37 (1.10, 1.70) compared with the lowest quartile. Results of these adjusted models showed no significant association across quartile categories of HbA1c concentrations and an increased risk of developing hypertension. The joint effect of hyperglycemia and overweight, older age or prehypertension resulted in further elevated ORs for hypertension than the absence of such an association. Higher FPG levels rather than HbA1c were strongly predictive of future hypertension among Japanese. Hyperglycemia along with older age, overweight and prehypertension contributed to identifying individuals at increased risk of developing hypertension.

Citing Articles

Association between elevated glycosylated hemoglobin levels and hypertension among US adults: NHANES 2011-2018.

Luo B, Xu W, Luo F, Zhang S, Li X BMC Cardiovasc Disord. 2025; 25(1):58.

PMID: 39871157 PMC: 11773917. DOI: 10.1186/s12872-025-04503-3.


The comorbidity burden of type 2 diabetes mellitus (T2DM): sex differences and associated factors among 830 cases in North-Eastern Morocco.

Kenfaoui I, Bouchefra S, Daouchi S, Benzakour A, Ouhssine M Diabetol Int. 2024; 15(4):814-827.

PMID: 39469545 PMC: 11513066. DOI: 10.1007/s13340-024-00750-5.


Degree of Blood Glucose Control and Risk of Hypertension in Chinese Adults with T2DM: A Cross-Sectional Study.

Zhang J, Yao X, Chen Y, Feng Q, Zhang Y, Jiang T Diabetes Metab Syndr Obes. 2024; 17:3227-3238.

PMID: 39224112 PMC: 11368100. DOI: 10.2147/DMSO.S462748.


Fasting Plasma Glucose and Glycated Hemoglobin Levels as Risk Factors for the Development of Hypertension: A Retrospective Cohort Study.

Luo B, Feng L, Bi Q, Shi R, Cao H, Zhang Y Diabetes Metab Syndr Obes. 2023; 16:1791-1798.

PMID: 37351279 PMC: 10284168. DOI: 10.2147/DMSO.S410670.


Association of hemoglobin A1c with the incidence of hypertension: A large prospective study.

Huang X, Qin C, Guo X, Cao F, Tang C Front Endocrinol (Lausanne). 2023; 13:1098012.

PMID: 36726461 PMC: 9884972. DOI: 10.3389/fendo.2022.1098012.


References
1.
Grayson P, Kim S, LaValley M, Choi H . Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2010; 63(1):102-10. PMC: 3016454. DOI: 10.1002/acr.20344. View

2.
Lipska K, de Rekeneire N, Van Ness P, Johnson K, Kanaya A, Koster A . Identifying dysglycemic states in older adults: implications of the emerging use of hemoglobin A1c. J Clin Endocrinol Metab. 2010; 95(12):5289-95. PMC: 2999974. DOI: 10.1210/jc.2010-1171. View

3.
He J, Klag M, Caballero B, Appel L, Charleston J, Whelton P . Plasma insulin levels and incidence of hypertension in African Americans and whites. Arch Intern Med. 1999; 159(5):498-503. DOI: 10.1001/archinte.159.5.498. View

4.
Tseng C, Yen A, Chiu S, Chen L, Chen H, Chang S . A predictive model for risk of prehypertension and hypertension and expected benefit after population-based life-style modification (KCIS No. 24). Am J Hypertens. 2011; 25(2):171-9. DOI: 10.1038/ajh.2011.122. View

5.
Klein R, Klein B, Lee K, Cruickshanks K, Moss S . The incidence of hypertension in insulin-dependent diabetes. Arch Intern Med. 1996; 156(6):622-7. View